Qualitative Study of Factors Affecting Patient, Caregiver and Physician Preferences for Treatment of Myeloma and Indolent Lymphoma

References

• Lee HP. Cancer Incidence and Mortality 2003-2012 and Selected Trends 1973-2012 in Singapore. 8 ed. National Registry of Disease Office, Singapore; 2016.
   Google Scholar
• Rosenberg PS, Barker KA, Anderson WF. Future distribution of multiple myeloma in the United States by sex, age, and race/ethnicity. Blood. 2015;125:410–412. doi:10.1182/blood-2014-10-609461
   PubMed Web of Science ®Google Scholar
• Tan D, Horning SJ, Hoppe RT, et al. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood. 2013;122:981–987. doi:10.1182/blood-2013-03-491514
   PubMed Web of Science ®Google Scholar
• Moreau P. How I treat myeloma with new agents. Blood. 2017;130:1507–1513. doi:10.1182/blood-2017-05-743203
   PubMed Web of Science ®Google Scholar
• Casulo C, Friedberg JW. Chemotherapy free treatment of indolent lymphoma. Hematol Oncol. 2017;35(Suppl 1):20–24. doi:10.1002/hon.2395
   Google Scholar
• Piechotta V, Jakob T, Langer P, et al. Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis. Cochrane Database Syst Rev. 2019;2019. doi:10.1002/14651858.CD013487
   Google Scholar
• Bonello F, Mina R, Boccadoro M, Gay F. Therapeutic monoclonal antibodies and antibody products: current practices and development in multiple myeloma. Cancers. 2019;12. doi:10.3390/cancers12010015
   Web of Science ®Google Scholar
• Apostolidis J, Mokhtar N, Al Omari R, Darweesh M, Al Hashmi H. Follicular lymphoma: update on management and emerging therapies at the dawn of the new decade. Hematol Oncol. Epub 2019 Dec 31.
   Web of Science ®Google Scholar
• Sindel A, Al-Juhaishi T, Yazbeck V. Marginal zone lymphoma: state-of-the-art treatment. Curr Treat Options Oncol. 2019;20:90. doi:10.1007/s11864-019-0687-5
   Web of Science ®Google Scholar
• Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet. 2015;385:2197–2208. doi:10.1016/S0140-6736(14)60493-1
   PubMed Web of Science ®Google Scholar
• Harrison N, Hewitt H, Pandya P, Reisel D. How Montgomery is reconfiguring consent in the UK. Lancet. 2018;392:102–104. doi:10.1016/S0140-6736(18)31124-3
   Web of Science ®Google Scholar
• Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2017;52:1893–1907.
   PubMed Web of Science ®Google Scholar
• Crowe M, Inder M, Porter R. Conducting qualitative research in mental health: thematic and content analyses. Aust N Z J Psychiatry. 2015;49:616–623. doi:10.1177/0004867415582053
   PubMed Web of Science ®Google Scholar
• Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15:398–405. doi:10.1111/nhs.2013.15.issue-3
   PubMed Web of Science ®Google Scholar
• Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–357. doi:10.1093/intqhc/mzm042
   PubMed Web of Science ®Google Scholar
• Fonseca R, Abouzaid S, Bonafede M, et al. Trends in overall survival and costs of multiple myeloma, 2000-2014. Leukemia. 2017;31:1915–1921. doi:10.1038/leu.2016.380
   PubMed Web of Science ®Google Scholar
• Ubel PA, Abernethy AP, Zafar SY. Full disclosure — out-of-pocket costs as side effects. N Engl J Med. 2013;369:1484–1486. doi:10.1056/NEJMp1306826
   PubMed Web of Science ®Google Scholar
• Kutikova L, Bowman L, Chang S, Long SR, Arning M, Crown WH. Medical costs associated with non-Hodgkin’s lymphoma in the United States during the first two years of treatment. Leuk Lymphoma. 2006;47:1535–1544. doi:10.1080/10428190600573325
   PubMed Web of Science ®Google Scholar
• Gordon N, Stemmer SM, Greenberg D, Goldstein DA. Trajectories of injectable cancer drug costs after launch in the United States. J Clin Oncol. 2017;36:319–325.
   Web of Science ®Google Scholar
• Karikios DJ, Schofield D, Salkeld G, Mann KP, Trotman J, Stockler MR. Rising cost of anticancer drugs in Australia. Intern Med J. 2014;44:458–463. doi:10.1111/imj.12399
   Web of Science ®Google Scholar
• Winn AN, Keating NL, Dusetzina SB. Factors associated with tyrosine kinase inhibitor initiation and adherence among medicare beneficiaries with chronic myeloid leukemia. J Clin Oncol. 2016;34:4323–4328. doi:10.1200/JCO.2016.67.4184
   PubMed Web of Science ®Google Scholar
• Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32:306–311. doi:10.1200/JCO.2013.52.9123
   PubMed Web of Science ®Google Scholar
• Fenn KM, Evans SB, McCorkle R, et al. Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract. 2014;10:332–338. doi:10.1200/JOP.2013.001322
   PubMedGoogle Scholar
• Kale HP, Carroll NV. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer. 2016;122:283–289. doi:10.1002/cncr.29808
   PubMed Web of Science ®Google Scholar
• Kent EE, Forsythe LP, Yabroff KR, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119:3710–3717. doi:10.1002/cncr.28262
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34:980–986. doi:10.1200/JCO.2015.64.6620
   PubMed Web of Science ®Google Scholar
• Shih YT, Chien CR. A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment. Cancer. 2017;123:928–939. doi:10.1002/cncr.30423
   PubMed Web of Science ®Google Scholar
• Zafar SY, Chino F, Ubel PA, et al. The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care. 2015;21:607–615.
   PubMed Web of Science ®Google Scholar
• Buzaglo JS, Miller MF, Karten C, et al. Cancer patient experience with financial counseling among participants of an online registry. J Clin Oncol. 2016;34:e18265–e. doi:10.1200/JCO.2016.34.15_suppl.e18265
   Web of Science ®Google Scholar
• Schnipper LE, Davidson NE, Wollins DS, et al. Updating the American society of clinical oncology value framework: revisions and reflections in response to comments received. J Clin Oncol. 2016;34:2925–2934. doi:10.1200/JCO.2016.68.2518
   PubMed Web of Science ®Google Scholar
• Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med. 2001;52:1865–1878. doi:10.1016/S0277-9536(00)00303-8
   PubMed Web of Science ®Google Scholar
• Swanson KA, Bastani R, Rubenstein LV, Meredith LS, Ford DE. Effect of mental health care and shared decision making on patient satisfaction in a community sample of patients with depression. Med Care Res Rev. 2007;64:416–430. doi:10.1177/1077558707299479
   PubMed Web of Science ®Google Scholar
• Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 1999;93:88–94. doi:10.1016/S0954-6111(99)90296-2
   PubMed Web of Science ®Google Scholar
• Janssen C, Ommen O, Pfaff H, Lefering R, Neugebauer E. Pre-traumatic, trauma- and treatment-related determinants of self-rated health after a severe trauma. Langenbeck’s archiv surg. 2009;394:539–546. doi:10.1007/s00423-008-0458-4
   Web of Science ®Google Scholar
• Burton D, Blundell N, Jones M, Fraser A, Elwyn G. Shared decision-making in cardiology: do patients want it and do doctors provide it? Patient Educ Couns. 2010;80:173–179. doi:10.1016/j.pec.2009.10.013
   PubMed Web of Science ®Google Scholar
• Ommen O, Thuem S, Pfaff H, Janssen C. The relationship between social support, shared decision-making and patient’s trust in doctors: a cross-sectional survey of 2197 inpatients using the Cologne Patient Questionnaire. Int J Public Health. 2011;56:319–327. doi:10.1007/s00038-010-0212-x
   PubMed Web of Science ®Google Scholar
• Arterburn D, Wellman R, Westbrook E, et al. Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs. Health Aff (Millwood). 2012;31:2094–2104. doi:10.1377/hlthaff.2011.0686
   Web of Science ®Google Scholar
• Oshima Lee E, Emanuel EJ. Shared decision making to improve care and reduce costs. N Engl J Med. 2013;368:6–8. doi:10.1056/NEJMp1209500
   PubMed Web of Science ®Google Scholar
• Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282:2313–2320. doi:10.1001/jama.282.24.2313
   PubMed Web of Science ®Google Scholar
• Alden DL, Friend J, Lee PY, et al. Who decides: me or we? Family involvement in medical decision making in eastern and Western countries. Med Decis Making. 2018;38:14–25. doi:10.1177/0272989X17715628
   PubMed Web of Science ®Google Scholar
• Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:Cd001431.
   PubMed Web of Science ®Google Scholar